InfuseAI is a technology company founded in 2018 that builds MLOps (Machine Learning Operations) tools designed to streamline machine learning workflows and data processes for enterprises. Its flagship product, the PrimeHub AI platform, enables organizations to develop, train, and deploy AI models up to 10 times faster by providing a consistent, flexible, and collaborative environment for data teams. InfuseAI serves industries such as medical, education, manufacturing, financial services, and healthcare, helping clients reduce costs, scale efficiently, and accelerate AI adoption. The company emphasizes data observability and workflow optimization to free teams to innovate and generate business value from data[1][2][3][4].
InfuseAI was co-founded in 2018 by Chia-Liang Kao and Liang-Bing after Kao’s involvement with the Taiwan AI Academy revealed a lack of suitable tools for managing AI model training and deployment environments. Recognizing that enterprises also struggled with managing AI workflows efficiently, they created InfuseAI to build tools that automate and streamline these processes. Early traction came from engagements with research institutes and enterprises in Taiwan, where InfuseAI helped customers cut model deployment times from days to under an hour. The company has since expanded its reach to Japan and Southeast Asia, supported by a recent Series A funding round[4][6].
InfuseAI rides the growing trend of MLOps, a critical enabler for enterprises to operationalize AI at scale. As AI adoption accelerates across industries, the need for streamlined workflows, collaboration, and observability in machine learning projects becomes paramount. InfuseAI’s timing is advantageous given the increasing complexity of AI pipelines and the scarcity of mature MLOps solutions in Asia compared to markets like the U.S. and Europe. By focusing on enterprise needs and open-source innovation, InfuseAI influences the broader ecosystem by lowering barriers to AI deployment and fostering collaboration across data teams, which is essential for AI-driven digital transformation[4].
InfuseAI is well-positioned to expand its footprint in Asia, particularly in Japan and Southeast Asia, leveraging its strong product-market fit and recent funding. Future trends shaping its journey include the rising demand for AI governance, explainability, and scalable MLOps platforms as enterprises deepen AI integration. InfuseAI’s open-source approach and remote-friendly culture may further accelerate innovation and community engagement. As AI becomes more pervasive, InfuseAI’s influence could grow by enabling more organizations to operationalize AI efficiently and responsibly, reinforcing its role as a key player in the MLOps landscape[4][6].
InfuseAI has raised $4.0M in total across 1 funding round.
InfuseAI's investors include HIVE Ventures.
InfuseAI has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in April 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2021 | $4.0M Series A | HIVE Ventures |